Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1146/annurev-pharmtox-010715-103507

http://scihub22266oqcxt.onion/10.1146/annurev-pharmtox-010715-103507
suck pdf from google scholar
C5586045!5586045!27732798
unlimited free pdf from europmc27732798    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27732798.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27732798      Annu+Rev+Pharmacol+Toxicol 2017 ; 57 (�): 107-23
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Targeted Protein Degradation by Small Molecules #MMPMID27732798
  • Bondeson DP; Crews CM
  • Annu Rev Pharmacol Toxicol 2017[Jan]; 57 (�): 107-23 PMID27732798show ga
  • Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of disease-relevant proteins. Here, we review recent advances in the use of small molecules to degrade proteins in a selective manner. First, we highlight all-small-molecule techniques with direct clinical application. Second, we describe techniques that may find broader acceptance in the biomedical research community that require little or no synthetic chemistry. In addition to serving as innovative research tools, these new approaches to control intracellular protein levels offer the potential to develop novel therapeutics targeting proteins that are not currently pharmaceutically vulnerable.



  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box